Goldman Cuts Short-Term Brent Forecast, But Says Recovery Likely By Summer

Goldman Sachs energy analysts have cut their near-term views on benchmark ICE Brent crude oil, but said the dip can be explained by “technical” factors and not a supply and demand imbalance that warranted a drop of more than 30% since October. “We believe that the volatility and magnitude of the sell-off were exacerbated by technical trading factors,” Goldman Sachs […]

Gilead Secures Japanese Regulatory Approval For Epclusa To Treat Chronic Hepatitis C virus

Gilead Sciences (GILD) said pre-market Tuesday that Japan’s Ministry of Health, Labour and Welfare has approved Epclusa for the treatment of adults with chronic hepatitis C virus (HCV) infection with decompensated cirrhosis as well as patients with chronic HCV infection without cirrhosis or with compensated cirrhosis who have had prior treatment with a direct-acting antiviral (DAA) therapy. Epclusa’s approval in […]